Achieve Life Sciences is trading 9.3% down in pre-market at $6.35 on October 14, 2026, with no specific catalyst identified. - The previous close was $7.00. - No new company announcement explaining the move was identified; the latest listed press release was its October 7 appointment of a marketing and communications executive. - The decline follows several weaker sessions. Available indicators are mixed and do not establish a specific catalyst or broader market cause; the reason remains unconfirmed pending further news.